肝硬化患者伴发食管静脉曲张破裂出血的死亡率为22～31％左右。近年来开展的内镜下硬化剂治疗可使70～95％的上述患者达到止血目的和较低的再出血率。生长抑素系一种14氨基酸多肽，具有降低肝硬化者肝静脉楔状压、肝脏血流和奇静脉血流的作用。为比较生长抑素和硬化剂在急性食 The mortality rate of cirrhotic patients with esophageal variceal bleeding is about 22 ~ 31%. In recent years, the endoscopic sclerosant treatment can make 70 ~ 95% of the above patients to achieve the purpose of hemostasis and a lower rate of rebleeding. Somatostatin is a 14 amino acid peptide that has the effect of reducing hepatic venous wedge pressure, hepatic blood flow and odd venous blood flow in cirrhotic patients. To compare somatostatin and sclerosant in acute food